CN Patent

CN115227658A — 一种氨己烯酸固体制剂组合物

Assigned to Shanghai Aucta Pharmaceuticals Co Ltd · Expires 2022-10-25 · 4y expired

What this patent protects

本申请公开了一种氨己烯酸固体剂型的制备方法，所述的方法制备得到的产品不含有聚维酮等辅料，粒度均匀，质量稳定。所述的产品固体剂型和稀释液混合后可快速制备成口服溶液，该溶液适用于CNS疾病的治疗，尤其适用于服药依从性不高儿童使用。

USPTO Abstract

本申请公开了一种氨己烯酸固体剂型的制备方法，所述的方法制备得到的产品不含有聚维酮等辅料，粒度均匀，质量稳定。所述的产品固体剂型和稀释液混合后可快速制备成口服溶液，该溶液适用于CNS疾病的治疗，尤其适用于服药依从性不高儿童使用。

Drugs covered by this patent

Patent Metadata

Patent number: CN115227658A
Jurisdiction: CN
Classification: —
Expires: 2022-10-25
Drug substance claim: No
Drug product claim: No
Assignee: Shanghai Aucta Pharmaceuticals Co Ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.